Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (7)

2020

  1. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis

    The Journal of clinical investigation, Vol. 130, Núm. 7, pp. 3848-3864

2019

  1. Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: A multicountry retrospective chart review

    Melanoma Management, Vol. 6, Núm. 4

2018

  1. Comparison of incision size and intraocular lens performance after implantation with three preloaded systems and one manual delivery system

    Clinical Ophthalmology, Vol. 12, pp. 1495-1503

  2. Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

    Breast Cancer Research and Treatment, Vol. 168, Núm. 2, pp. 357-364

2014

  1. Phase lb study of buparlisib plus trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on trastuzumab-based therapy

    Clinical Cancer Research, Vol. 20, Núm. 7, pp. 1935-1945

2013

  1. Design, synthesis, and functional evaluation of leukocyte function associated antigen-1 antagonists in early and late stages of cancer development

    Journal of Medicinal Chemistry, Vol. 56, Núm. 3, pp. 735-747

2007

  1. Molecular response to aromatase inhibitor treatment in primary breast cancer

    Breast Cancer Research, Vol. 9, Núm. 3